PAR 1.79% 27.5¢ paradigm biopharmaceuticals limited..

Community Adoption / Mr Federer, page-73

  1. 9,686 Posts.
    lightbulb Created with Sketch. 1234
    I'm unclear as to where you're source your "trend data" from MM?

    iPPS producing a net 65% reduction in BML Volume in the NRS 4-6 strata at day 53 (i.e. 2 weeks post last treatment) and this reduction was by any measure statistically significant over placebo (P=0.03)
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.